CD274 and neoplasm: In both cases, PD-L1 interacts with PD-1, a homologous ligand on the surface of T cells, which can inhibit the function of T cells, alter their phenotypes, induce T cell tolerance, inhibit T cell proliferation, and reduce cytokine production, blocking T cell recognition of tumor cells (53, 54).